Peptide Receptor Radionuclide Therapy for the Treatment of Pancreatic Neuroendocrine Tumors: Recent Insights

Peptide receptor radionuclide therapy (PRRT) is a paradigm shifting approach to the treatment of neuroendocrine tumors. Although there are no prospective randomized trials directly studying PRRT in pancreatic neuroendocrine tumors (panNETs), there are data to suggest benefit in this patient populati...

Descripción completa

Detalles Bibliográficos
Autores principales: Starr, Jason S, Sonbol, Mohamad Bassam, Hobday, Timothy J, Sharma, Akash, Kendi, Ayse Tuba, Halfdanarson, Thorvardur R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205451/
https://www.ncbi.nlm.nih.gov/pubmed/32431509
http://dx.doi.org/10.2147/OTT.S202867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205451/
https://www.ncbi.nlm.nih.gov/pubmed/32431509
http://dx.doi.org/10.2147/OTT.S202867

Ejemplares similares